JP2025513462A5 - - Google Patents

Info

Publication number
JP2025513462A5
JP2025513462A5 JP2024562090A JP2024562090A JP2025513462A5 JP 2025513462 A5 JP2025513462 A5 JP 2025513462A5 JP 2024562090 A JP2024562090 A JP 2024562090A JP 2024562090 A JP2024562090 A JP 2024562090A JP 2025513462 A5 JP2025513462 A5 JP 2025513462A5
Authority
JP
Japan
Prior art keywords
alkyl
independently selected
pharmaceutically acceptable
prodrug
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024562090A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025513462A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2023/050523 external-priority patent/WO2023201423A1/en
Publication of JP2025513462A publication Critical patent/JP2025513462A/ja
Publication of JP2025513462A5 publication Critical patent/JP2025513462A5/ja
Pending legal-status Critical Current

Links

JP2024562090A 2022-04-19 2023-04-18 セロトニン作動薬としてのインドリン誘導体に関連する障害の治療に有用なセロトニン作動薬としてのインドリン誘導体 Pending JP2025513462A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263332450P 2022-04-19 2022-04-19
US63/332,450 2022-04-19
PCT/CA2023/050523 WO2023201423A1 (en) 2022-04-19 2023-04-18 Indoline derivatives as serotonergic agents useful for the treatment of disorders related thereto

Publications (2)

Publication Number Publication Date
JP2025513462A JP2025513462A (ja) 2025-04-24
JP2025513462A5 true JP2025513462A5 (enExample) 2026-04-23

Family

ID=88418733

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024562088A Pending JP2025513461A (ja) 2022-04-19 2023-04-18 セロトニン作動薬としてのインドリン誘導体に関連する障害の治療に有用なセロトニン作動薬としてのインドリン誘導体
JP2024562090A Pending JP2025513462A (ja) 2022-04-19 2023-04-18 セロトニン作動薬としてのインドリン誘導体に関連する障害の治療に有用なセロトニン作動薬としてのインドリン誘導体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2024562088A Pending JP2025513461A (ja) 2022-04-19 2023-04-18 セロトニン作動薬としてのインドリン誘導体に関連する障害の治療に有用なセロトニン作動薬としてのインドリン誘導体

Country Status (10)

Country Link
US (2) US20260083703A1 (enExample)
EP (2) EP4511369A4 (enExample)
JP (2) JP2025513461A (enExample)
KR (2) KR20250036719A (enExample)
CN (2) CN119522212A (enExample)
AU (2) AU2023255414A1 (enExample)
CA (2) CA3248170A1 (enExample)
IL (2) IL316416A (enExample)
MX (2) MX2024012865A (enExample)
WO (2) WO2023201423A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4581028A1 (en) * 2022-08-29 2025-07-09 Mindset Pharma Inc. Indoline derivatives as serotonergic agents useful for the treatment of disorders related thereto
WO2025104491A1 (en) * 2023-11-14 2025-05-22 Mindset Pharma Inc. Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto
AU2024397012A1 (en) * 2023-12-15 2026-07-30 10763942 Canada Inc. (Dba. Purminds Neuropharma) Heterocyclic compounds and methods of preparation thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737725B1 (fr) * 1995-08-08 1997-10-31 Valentonine Nouveaux derives acyles de la melatonine et d'analogues melatoninergiques, leur procede de preparation et leur utilisation en tant que medicament
CN1289479C (zh) * 1996-11-26 2006-12-13 Nps艾里利克斯有限公司 作为5－ht1d受体配位体的5－环吲哚化合物
JP2003524571A (ja) * 1997-07-25 2003-08-19 ハー・ルンドベック・アクチエゼルスカベット インドール−及び２，３−ジヒドロインドール誘導体、その製造方法及びその使用方法
GB9819033D0 (en) * 1998-09-01 1998-10-28 Cerebrus Ltd Chemical compounds VI
WO2000034266A1 (en) * 1998-12-11 2000-06-15 Eli Lilly And Company Indole derivatives and their use as 5-ht1f agonists
AU2003236207A1 (en) * 2002-05-31 2003-12-19 H. Lundbeck A/S The hydrochloride of (s)-(+)-3-(1-(2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl)-1,2,3,6-tetrahydropyridin-4-yl)-6-chloro-1h-indole
WO2005084664A1 (ja) * 2004-03-08 2005-09-15 Kanazawa University Technology Licensing Organization Ltd. インドール誘導体及びその用途
JP5452223B2 (ja) * 2006-07-24 2014-03-26 テトラロジック ファーマシューティカルズ コーポレーション Ｉａｐ阻害剤
AU2021215709A1 (en) * 2020-02-04 2022-09-01 Mindset Pharma Inc. 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders

Similar Documents

Publication Publication Date Title
JP2025513461A5 (enExample)
JP2023513679A5 (enExample)
JP2024508922A5 (enExample)
JP7607732B2 (ja) 置換ピロロピリミジンｊａｋ阻害剤ならびにこれを作製および使用する方法
IL295371A (en) Psilocyin derivatives as serotonergic psychedelics for the treatment of central nervous system disorders
ES2935476T3 (es) Esteroides neuroactivos, composiciones y usos de los mismos
JP2023553094A5 (enExample)
JP2019520416A5 (enExample)
JP2023512821A5 (enExample)
JP2024508545A5 (enExample)
IL316401A (en) Indoline derivatives as estrogenic agents for the treatment of disorders
JP2018505898A5 (enExample)
RU2009103307A (ru) ПРОИЗВОДНЫЕ ИМИДАЗО[1, 2-a]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ТЕРАПИИ
JP6046149B2 (ja) Ｈ３受容体阻害剤としてのピペリジン及びピペラジン環を含むカルバメート／尿素誘導体
AU2017207991A1 (en) Pyridazine derivatives as EAAT2 activators
JP7794910B2 (ja) Ｅａａｔ２活性化因子およびその使用方法
JP2022536773A5 (enExample)
JP2024517498A5 (enExample)
JP2013513615A (ja) 脂肪酸アミドヒドロラーゼのアゾ環状阻害薬
JPWO2010150840A1 (ja) Ｎ−置換−環状アミノ誘導体
RS58053B1 (sr) [1,2,4] triazolo [1,5-a] pirimidin derivati kao proteazomski inhibitori protozoa za tretman parazitskih bolesti kao što je lišmanijaza
KR20170123329A (ko) 단백질병증을 치료하기 위한 방법
JP2024534572A5 (enExample)
JP2017523201A5 (enExample)
ES2548683T3 (es) Amidas del ácido 4-(5-isoxazolil o 5-pirrazolil-1,2,4-oxadiazol-3-il)-mandélico como agonistas de receptor de esfingosina-1-fosfato 1